156 related articles for article (PubMed ID: 30212603)
1. Preparation of Ligand-Targeted Drug Conjugates for Cancer Therapy and Their Evaluation In Vitro.
Krishnan MA; Sengupta S; Chelvam V
Curr Protoc Chem Biol; 2018 Dec; 10(4):e50. PubMed ID: 30212603
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Evaluation of Ligand Targeted Drug Conjugates for Cancer Therapy.
Krishnan MA; Pandit A; Chelvam V
Curr Protoc Chem Biol; 2018 Dec; 10(4):e49. PubMed ID: 30212611
[TBL] [Abstract][Full Text] [Related]
3. Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach.
Rana A; Bhatnagar S
Bioorg Chem; 2021 Jul; 112():104946. PubMed ID: 33989916
[TBL] [Abstract][Full Text] [Related]
4. Small Molecule-Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs.
Zhang J; Hu F; Aras O; Chai Y; An F
ChemMedChem; 2024 Jun; 19(11):e202300720. PubMed ID: 38396351
[TBL] [Abstract][Full Text] [Related]
5. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment.
Paulus J; Sewald N
J Pept Sci; 2024 Jul; 30(7):e3561. PubMed ID: 38382900
[TBL] [Abstract][Full Text] [Related]
6. PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation.
Machulkin AE; Uspenskaya AA; Zyk NY; Nimenko EA; Ber AP; Petrov SA; Shafikov RR; Skvortsov DA; Smirnova GB; Borisova YA; Pokrovsky VS; Kolmogorov VS; Vaneev AN; Ivanenkov YA; Khudyakov AD; Kovalev SV; Erofeev AS; Gorelkin PV; Beloglazkina EK; Zyk NV; Khazanova ES; Majouga AG
Eur J Med Chem; 2022 Jan; 227():113936. PubMed ID: 34717125
[TBL] [Abstract][Full Text] [Related]
7. Chemistry and Chemical Biology of Therapeutically Important Compounds.
Disney MD
Bioorg Med Chem; 2016 Sep; 24(17):3875. PubMed ID: 27460698
[No Abstract] [Full Text] [Related]
8. Structure-based design of HSPA5 inhibitors: from peptide to small molecule inhibitors.
Huang M; Li Z; Li D; Walker S; Greenan C; Kennedy R
Bioorg Med Chem Lett; 2013 May; 23(10):3044-50. PubMed ID: 23562057
[TBL] [Abstract][Full Text] [Related]
9. Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship.
Leamon CP; Vlahov IR; Reddy JA; Vetzel M; Santhapuram HK; You F; Bloomfield A; Dorton R; Nelson M; Kleindl P; Vaughn JF; Westrick E
Bioconjug Chem; 2014 Mar; 25(3):560-8. PubMed ID: 24564229
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates.
Khaybullin RN; Liang X; Cisneros K; Qi X
Future Med Chem; 2015; 7(18):2419-28. PubMed ID: 26653151
[TBL] [Abstract][Full Text] [Related]
11. Delivering aminopyridine ligands into cancer cells through conjugation to the cell-penetrating peptide BP16.
Soler M; González-Bártulos M; Figueras E; Massaguer A; Feliu L; Planas M; Ribas X; Costas M
Org Biomol Chem; 2016 Apr; 14(17):4061-70. PubMed ID: 27055538
[TBL] [Abstract][Full Text] [Related]
12. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
13. iVS analysis to evaluate the impact of scaffold diversity in the binding to cellular targets relevant in cancer.
Cilibrizzi A; Floresta G; Abbate V; Giovannoni MP
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):44-50. PubMed ID: 30362379
[TBL] [Abstract][Full Text] [Related]
14. An update on small molecules targeting CXCR4 as starting points for the development of anti-cancer therapeutics.
Grande F; Giancotti G; Ioele G; Occhiuzzi MA; Garofalo A
Eur J Med Chem; 2017 Oct; 139():519-530. PubMed ID: 28826086
[TBL] [Abstract][Full Text] [Related]
15. Multivalent peptidomimetic conjugates: a versatile platform for modulating androgen receptor activity.
Levine PM; Imberg K; Garabedian MJ; Kirshenbaum K
J Am Chem Soc; 2012 Apr; 134(16):6912-5. PubMed ID: 22509763
[TBL] [Abstract][Full Text] [Related]
16. Small molecule KDM4s inhibitors as anti-cancer agents.
Lin H; Li Q; Li Q; Zhu J; Gu K; Jiang X; Hu Q; Feng F; Qu W; Chen Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):777-793. PubMed ID: 29651880
[TBL] [Abstract][Full Text] [Related]
17. Hydrophilic Small Molecules That Harness Transthyretin To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents.
Pal A; Albusairi W; Liu F; Tuhin MTH; Miller M; Liang D; Joo H; Amin TU; Wilson EA; Faridi JS; Park M; Alhamadsheh MM
Mol Pharm; 2019 Jul; 16(7):3237-3252. PubMed ID: 31136717
[TBL] [Abstract][Full Text] [Related]
18. A small molecule inhibits protein disulfide isomerase and triggers the chemosensitization of cancer cells.
Eirich J; Braig S; Schyschka L; Servatius P; Hoffmann J; Hecht S; Fulda S; Zahler S; Antes I; Kazmaier U; Sieber SA; Vollmar AM
Angew Chem Int Ed Engl; 2014 Nov; 53(47):12960-5. PubMed ID: 25256790
[TBL] [Abstract][Full Text] [Related]
19. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
Wang Y; Xin D; Liu K; Zhu M; Xiang J
Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
[TBL] [Abstract][Full Text] [Related]
20. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
